OP-011 Do We Have to be Affraid of Dual Antiplatelet Therapy




Introduction


Patients with ACS who needs CABG are surgical challenge due to their instability, potential unrecognized co-morbidity, and the need for urgent treatment. Dual antiplatelet therapy (clopidogrel + aspirin) has to be given to almost all patients before coronarography. The same therapy becomes a threat to cardiac surgeons as it may have deleterious effects on surgical haemostasis.




Material and Methods


122 patients with ACS were surgically revascularized using extracorporeal circulation in the first 10 days after the coronarography by one surgical team in the 5 years period. Patients were stratified into two groups: 65 patients operated within 4 days (group 1), and 57 patients operated from 5-Th to 10-Th day after the clopidogrel discontinuation (group 2). Patients who were underwent reoperation, combined procedures, or off-pump revascularization were excluded.

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Nov 30, 2016 | Posted by in CARDIOLOGY | Comments Off on OP-011 Do We Have to be Affraid of Dual Antiplatelet Therapy

Full access? Get Clinical Tree

Get Clinical Tree app for offline access